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Functional Analysis of Chicken Sox2 Enhancers
Highlights an Array of Diverse Regulatory Elements
that Are Conserved in Mammals
Uchikawa et al., 1999; Uwanogho et al., 1995). Further-
more, a recent report investigating the neural primordia
of embryos indicates that Sox2 expression is highly cor-
related with the multipotent neural stem cell state (Cai
et al., 2002). Because Sox2 is expressed more or less
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1-3 Yamadaoka uniformly in the early neural tube, it is regarded as a
“pan-neural” marker in early embryonic stages (DarnellSuita, Osaka 565-0871
Japan et al., 1999; Streit et al., 1997). In addition, Sox2 is com-
monly expressed in sensory placodes (Uchikawa et al.,
1999).
Another important aspect of Sox2 regulation is thatSummary
its expression in the CNS is first activated upon neural
induction elicited by signals from the organizer (Fernan-Sox2 expression marks neural and sensory primordia
dez-Garre et al., 2002; Streit et al., 1997). Therefore,at various stages of development. A 50 kb genomic
initiation of Sox2 expression must be an essential partregion of chicken Sox2 was isolated and scanned for
of the mechanism of neural induction. These aspects ofenhancer activity utilizing embryo electroporation, re-
Sox2 expression in the early embryo are common amongsulting in identification of a battery of enhancers. Al-
vertebrates (Kishi et al., 2000; Rex et al., 1997; Streit etthough Sox2 expression in the early embryonic CNS
al., 1997; Wood and Episkopou, 1999).appears uniform, it is actually pieced together by five
To elucidate the molecular mechanisms underlyingseparate enhancers with distinct spatio-temporal
Sox2 regulation in the early neural tissues, we analyzedspecificities, including the one activated by the neural
a wide genomic region encompassing the Sox2 gene.induction signals emanating from Hensen’s node. En-
Here we report the following findings: (1) Sox2 in thehancers for Sox2 expression in the lens and nasal/otic
neural tissues is regulated by multiple extragenic en-placodes and in the neural crest were also determined.
hancers having distinct spatio-temporal specificities, inThese functionally identified Sox2 enhancers exactly
spite of its apparently uniform “pan-neural” expression;correspond to the extragenic sequence blocks con-
(2) one of the enhancers responds to the neural inductionspicuously conserved between chicken and mam-
signals emanated from Hensen’s node, opening amals, which are not discernible by sequence compari-
straightforward access to the mechanism of neural in-son among mammals.
duction; and (3) consistent with the conserved Sox2
expression pattern, the functionally identified Sox2 en-Introduction
hancers exactly correspond to extragenic sequence
blocks conspicuously conserved between the chickenSOX proteins are a group of transcriptional regulators
and mouse/human, but these blocks are obscured whenhaving analogous HMG domains for their DNA binding,
mouse and human sequences are compared becauseand are highly involved in regulation of cell differentia-
of the existence of wider spans of sequence similarity.tion (Kamachi et al., 2000; Pevny and Lovell-Badge,
Thus, the enhancers associated with a genetic locus are1997; Wegner, 1999). There are roughly 20 Sox genes
accurately predictable as sequence blocks conservedin each vertebrate species (Schepers et al., 2002), which
between chicken and mammals.are classified into nine groups, according to the organi-
zation of the encoding proteins and the HMG domain
sequences. Cumulative evidence indicates that SOX Results and Discussion
proteins form a complex with their partner transcription
factors unique to each SOX group, thereby selecting Detailed Sox2 Expression Patterns in Early
Chicken Embryosgroup-specific and partner-dependent regulatory target
genes (Kamachi et al., 2000, 2001; Wilson and Koopman, Sox2 expression consistently marks neural primordial
cells at various stages of development. Sox2 expression2002).
Among the Sox genes, those belonging to group B1 in the CNS is first activated by neural induction elicited
by signals from the organizer. In chicken embryos, Sox2(Sox1, Sox2, and Sox3) are expressed widely in the ner-
vous system, and are implicated in neural development expression is initiated at stage 4 (st. 4) in the presumptive
cephalic neural plate, the posteriorly notched horse-(Collignon et al., 1996; Pevny et al., 1998; Rex et al.,
1997; Uchikawa et al., 1999; Uwanogho et al., 1995; shoe-shaped area surrounding Hensen’s node (Figure
1A, compare st. 3 and st. 4). As Hensen’s node movesWood and Episkopou, 1999). In particular, Sox2 expres-
sion consistently marks neural primordial cells at various posteriorly, a newer Sox2-expressing area is continu-
ously generated and added to the region of previouslystages of development (Cai et al., 2002; Kishi et al., 2000;
Mizuseki et al., 1998; Rex et al., 1997; Streit et al., 1997; activated Sox2 (Figure 1A, st. 5–8). At neurulation stages
when the sheet of Sox2-expressing cells converges (Fig-
ure 1A, st. 8) and forms a neural tube, posterior addition*Correspondence: kondohh@fbs.osaka-u.ac.jp
of new Sox2-expressing cells still continues (Figure 1A,2 Present address: Hitachi, Ltd., Life Science Group, 1-3-1 Minami-
dai, Kawagoe, Saitama, 350-1165 Japan. st. 8–14).
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Figure 1. Development and Electroporation of Chicken Embryo
(A) Expression of Sox2 in the early chicken embryo. Sox2 expression is initiated in the presumptive cephalic neural plate at st. 4 in the area
surrounding Hensen’s node (arrowhead). The Sox2-expressing area extends posteriorly with posterior regression of the node. After st. 10,
Sox2 expression is induced in the cephalic placodes, and their derivatives are indicated by a bracket.
(B) To identify the regulatory elements responsible for expression of Sox2 in the early CNS and placodes, we cloned an 50 kb genomic
region encompassing the Sox2 gene of the chicken, prepared a number of small fragments scanning the whole region, and placed the
fragments in a reporter expressing EGFP.
(C) The reporter constructs were electroporated into chicken embryos under New culture from st. 4 to st. 7, and expression of EGFP in tissues
of the embryo was examined after 6–24 hr. LacZ or DsRed1 genes driven by nonspecific enhancer/promoters were coelectroporated to
monitor electroporation.
Around st. 10, Sox2 expression is induced in the sec- determined, and various portions were analyzed for en-
hancer activity.ond set of ectodermal cell populations, the sensory plac-
odes (Figure 1A, st. 10–14). Sox2 is also activated in Chicken embryos at st. 4 under New culture were
electroporated in the epiblast and ectoderm with EGFPthe ventral to lateral parts of the head ectoderm. The
expression in the lateral head ectoderm is extinguished reporter constructs carrying various genomic fragments
of the Sox2 locus (Figure 1B), and expression of theby stage 11, except for the region contacted by the optic
vesicle at st. 10, which is marked by induction of strong EGFP gene in the developing embryos (Figure 1C) was
examined. Successful electroporation of wide tissue ar-Sox2 expression and develops into the lens placode
(Kamachi et al., 1998). The lens placode then invaginates eas was confirmed by coelectroporation of LacZ or
DsRed1 vectors carrying a nonspecific enhancer. Atand forms a lens vesicle, the primitive lens (st. 14–16).
Strong Sox2 expression continues in later lens develop- least six independent electroporations were done for
each genomic fragment, which gave essentially thement in the chicken (Kamachi et al., 1998; Uchikawa et
al., 1999). same results.
Initial screening using DNA fragments5 kb long indi-
cated association of a certain enhancer activity with
Identification of Sox2 Enhancers most of the fragments examined, whereas the specificity
Definition of regulatory sequences of the Sox2 gene of each enhancer was distinct. We narrowed down the
accounting for its expression in the early CNS and plac- DNA fragments bearing the enhancer activity step by
odes is essential to elucidate the molecular mechanisms step to a few hundred base pairs as shown in Figure 2.
underlying the development of these tissues. A roughly We also included in the analysis the DNA fragments
50 kb region of the chicken genome covering the Sox2 corresponding to the conserved sequence blocks iden-
locus (16.7 kb upstream and 32.5 kb downstream; Figure tified by comparison of chicken and mammalian se-
quences as described below. Through this analysis, we2) was isolated, the whole nucleotide sequence was
Sox2 Neurosensory Enhancers
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Figure 2. Identification of Enhancers Responsible for Sox2 Expression in Various Domains of the CNS and Sensory Placodes
The genomic fragments that cover the 50 kb Sox2 locus of the chicken were tested for enhancer activity by electroporation of embryos.
Position 1 indicates the translational start site. The Sox2 coding sequence shown in green has no intron. Fragments shown in red exhibited
an enhancer activity by electroporation of st. 4 embryos and observation at st. 5–20. An active fragment and its subfragments generally
showed the same enhancer activity. Fragments electroporated in the st. 11 neural tube and showing enhancer activity are indicated by *
(activity in the spinal cord) or ** (activity in the dorsal root ganglia). Fragments of 7.6–14 and 21–25 are used in Figures 4E and 4F. In the lower
map, neural enhancers detectable in stages before st. 20 are indicated by red boxes, those detected in later stages are indicated by purple
boxes, and the placodal enhancers are indicated by ocher boxes. Their domain specificities in the CNS and placodes are indicated.
identified eight distinct enhancers active in different do- In later phases, the activity of enhancer N-1 is always
confined to the region surrounding the node, and is notmains of the early CNS and sensory placodes, as sum-
retained in more rostral regions where the enhancer hadmarized in Figure 2 (red and ocher boxes). These en-
the activity in earlier periods; this argues that enhancerhancers were active in both dorsal and ventral
N-1 is primarily involved in the activation of Sox2 expres-compartments of respective domains of the CNS.
sion in the process to generate the neural plate.
It is indicated that in early neurogenesis (e.g., st. 6),
Enhancer N-1 Responding to Neural the epiblast cells in the proximity of the node are newly
Induction Signals induced to take part in the neural plate, whereas later in
Activity of the enhancer N-1 accounts for the Hensen’s neurogenesis, neural precursors surrounding the node
node-induced Sox2 expression. A few hours after elec- proliferate and migrate caudally along with the node
troporation (st. 5), EGFP fluorescence reflecting the en- (Brown and Storey, 2000; Darnell et al., 1999; Mathis et
hancer activity appeared in the area surrounding al., 2001; Storey et al., 1992). In both phases, enhancer
Hensen’s node. Continuous observations of the same N-1 is active in the cell population that surrounds the
developing embryos indicated that the tissue area sup- node and is in the nascent phase of neurogenesis.
porting the enhancer activity moved caudally, always
surrounding the node undergoing posterior regression Enhancers for Specific Domains of the CNS
(Figure 3A). Use of a destabilized form of EGFP (d2EGFP) In other regions of the neural plate, enhancers N-2 to
did not significantly alter the tissue area of the EGFP N-5 regulate Sox2 expression.
fluorescence, indicating that the EGFP reporter expres- Enhancer N-2 is activated around st. 5 analogous to
sion follows the temporal change of the enhancer ac- enhancer N-1, and covers the most rostral part of the
tivity. CNS. The activity of N-2 is initially broad, covering the
We explanted Hensen’s node of quail to nonneural region rostral to Hensen’s node before st. 7 (Figure 4A,
regions of st. 4 chicken embryos, in the distal parts of 6 hr), and at st. 9–11 the activity covers prosencephalon,
area pellucida (embryogenic region) or in area opaca mesencephalon, and rostral rhombencephalon (Figure
(extraembryonic region), which had been electroporated 4A, st. 11). The activity is gradually restricted more ros-
with the N-1/EGFP construct beforehand. The Hensen’s trally, and eventually to the dorsal telencephalon (Figure
node explant induced the activity of the enhancer at 4A and data not shown).
these ectopic sites, in parallel with ectopic induction of Enhancer N-3 has the activity detectable after st. 8 in
the endogenous Sox2 as previously reported (Streit et the neural folds roughly corresponding to the level of
al., 1997; Figure 3B). These observations indicate that the mesencephalon. Later the activity of enhancer N-3
the enhancer N-1 activates Sox2 expression responding covers the retina, diencephalon, and the rostral mesen-
cephalon (Figure 4B).to neural induction signals from Hensen’s node.
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Enhancer N-4 has an activity detectable after st. 10 in
the mesencephalon, rhombencephalon, and the spinal
cord, in which the caudal margin of the expression lies
around the level of somite formation. The enhancer ac-
tivity in the rhombomeres r2–r4 is significantly lower
than other regions (Figure 4C). Enhancer N-4 is also
active in the lateral and ventral head ectoderm, account-
ing for the ectodermal Sox2 expression (Figure 4C,
arrow).
Enhancer N-5 is active after st. 12 exclusively in the
rhombencephalon at the levels r2–r4 in a way comple-
menting the activity of enhancer N-4 (Figure 4D).
Thus, enhancers N-1 to N-5 individually regulate Sox2
in distinct domains of the CNS, and combination of the
expression domains covers the entire region of the CNS.
This indicates that “pan-neural” expression of Sox2 is
actually brought about by a patchwork of region-specific
enhancer activities.
The nucleotide sequences of these early neural en-
hancers are shown in Figure 5. Inspection of these se-
quences indicates that potential binding sites for SOX/
LEF/TCF (HMG domain) transcription factors (Schilham
and Clevers, 1998) are distributed among the enhancers.
The sequence ATTA, characteristic of homeodomain
protein binding sites, is also common. In particular, po-
tential sites for POU family proteins, a subclass of the
homeodomain proteins, are carried by enhancers N-2
and N-3. The occurrence of SOX/LEF/TCF factor binding
sites raises the possibility that these enhancers are acti-
vated by SOX2 itself, which is first turned on by the
action of enhancer N-1, and suggests an autoregulatory
loop in maintaining enhancer activity. Alternatively, they
could be under regulation of the Wnt signaling system,
having LEF-1/TCF transcription factors as their down-
stream target (Clevers and van de Wetering, 1997).
It has been indicated that HMG domain proteins and
Figure 3. Activity of Enhancer N-1 Responding to Neural Induction
Signals
(A) The same embryo electroporated with EGFP reporter vector
carrying enhancer N-1 at st. 4 and observed at different stages of
development under New culture. Arrowheads indicate the position
of Hensen’s node. EGFP fluorescence representing enhancer activ-
ity appears after a few hr in the region surrounding Hensen’s node,
and the region with the activity changes location as the node moves
caudally. The LacZ panel shows expression of coelectroporated
nonspecific LacZ gene, confirming gene transfer in a wide area of
the embryo.
(B) Effect of Hensen’s node explant on the activity of enhancer N-1.
A piece of node from the quail embryo (arrowhead) was grafted in
st. 4 embryos, which had been electroporated with N-1-bearing
EGFP reporter plasmid.
Upper: graft at the edge of area pellucida. Left: an embryo 12 hr
after the graft. The enhancer is activated (arrowhead) in the chicken
tissues surrounding the graft, in addition to those surrounding the
authentic node. The inset shows a bright field view of the same
embryo. Right: the same embryo fixed after 24 hr and processed
for Sox2 in situ hybridization, showing induction of endogenous
Sox2 expression in response to the node graft.
Lower: graft in area opaca. Left: an embryo 12 hr after the graft,
processed for EGFP in situ hybridization and color development with
INT/BCIP. Right: the same specimen after removal of the pigment
deposit of INT/BCIP processed for Sox2 in situ hybridization and
color development with NBT/BCIP.
st., developmental stages; h, hours after electroporation.
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homeodomain proteins often interact in regulation of arrow). In embryos where one of the optic vesicles failed
to make contact with the lateral ectoderm under thetranscription of the target genes (Dailey and Basilico,
2001; Kamachi et al., 2000). The regulation of nestin culture condition, this enhancer was not activated in
that side (data not shown). Enhancer N-3 remains activegene, which is also expressed in the neural primordial
cells, requires binding of a POU protein (e.g., Brn1) to in the lens-forming cells up to early lens vesicle stage
(st. 14). Then late lens enhancer, L, becomes active anda site in its neural enhancer (Josephson et al., 1998).
We have recently shown that the nestin enhancer is also persists to later lens development, which was identified
by electroporation of st. 10 embryo head ectoderm (Fig-dependent on the binding of a SOX protein (e.g., SOX2;
S. Tanaka, Y.K., N. Jin, H. Hamada, and H.K., unpub- ure 4J, arrow).
It is interesting to note that the enhancer involved inlished results). It is tempting to speculate that at least
in the rostral domain of the early CNS where Sox2 ex- lens induction (N-3) is distinct from that in neural induc-
tion (N-1), implying that different extracellular signalspression is activated by enhancers N-2 and N-3, the
neural primordial cells are maintained by a combinatorial induce these tissues.
action of POU and SOX transcription factors.
Enhancers N-1, N-4, and N-5 have the binding sites Nasal and Otic Placode Enhancers
for Zfhx (zinc finger-homeodomain) family proteins EF1 The analysis employing electroporation of st. 4 embryos
(Sekido et al., 1994, 1997)/SIP1 (Verschueren et al., 1999) also identified placodal enhancers. Two enhancers,
in their nucleotide sequences, although its significance NOP-1 and NOP-2, are found which are individually ac-
remains to be examined. tive in early nasal and otic placodes (Figures 4H and
4I). This observation implies that development of these
placodes is under analogous regulation at least in theEnhancers for Later Neural Development
The enhancers active in later developmental stages of initial phases.
the CNS were also investigated by electroporating st.
11 embryos in ovo in the ventricular zone of the spinal Matching of the Enhancers to the Array of Sequence
cord, and assessing enhancer activities at st. 23 (48 hr Blocks Conserved between Chicken
later). A few regions located 3 of the Sox2 gene have and Mammals
analogous enhancer activity in the ventricular zone of As summarized in Figure 2, we identified an array of
the spinal cord (Figure 2, fragments marked by *; Figures enhancers with distinct spatio-temporal coverages that
4E and 4F). Besides enhancer N-4 active from the early account for expression of Sox2 in the embryonic CNS
spinal cord, a few other regions, such as conserved blocks and sensory placodes. Because Sox2 expression pat-
18 and 22 (see below) designated as enhancers SC-1 and tern in these tissues is well conserved between the
SC-2, respectively, were active in the spinal cord. chicken and the mouse (Kamachi et al., 1998; Rex et
The same analysis also indicated an enhancer activity al., 1997; Uwanogho et al., 1995; Wood and Episkopou,
in the dorsal root ganglia, reflecting the Sox2 expression 1999), we compared the nucleotide sequences of the
in the neural population of neural crest cells (Figure Sox2-flanking regions between chicken and mouse, and
4G; Uchikawa et al., 1999; Uwanogho et al., 1995). The between chicken and human, using a stringent criterion
activity was associated with the fragment located the to assess similarity (60% identity in a stretch longer
most 3 of the region of the analysis (Figure 2, fragments than 100 bp). The analysis revealed 25 blocks of se-
marked by **), which was narrowed down to the con- quence highly conserved between chicken and mammals
served sequence block 25 designated as enhancer NC-1 and distributed in the region of analysis. Most remark-
(neural crest-1; see below). ably, all ten identified neural and placodal enhancers
(except for enhancer L; Figure 2) match these blocks
(Figure 6A; Table 1). The sequence alignment of theEnhancers for Lens Development
In previous work, we identified three distinct stages of neural enhancers N-1 to N-5 derived from the three ani-
mal species (Figure 5) confirms the high degree of con-Sox2 expression in the early lens development starting
from the lateral head ectoderm (Kamachi et al., 1998): servation, including the putative transcription factor
binding sites. Previously, Zappone et al. (2000) de-(1) low Sox2 expression in the ventral to lateral head
ectoderm from before the stages of contact by the optic scribed an enhancer located 4 kb 5 of mouse Sox2
gene, and active in the dorsal telencephalon of midges-vesicle; (2) high Sox2 expression induced by the contact
of the optic vesicle (st. 11) and leading to lens placode tation mouse embryos. This enhancer corresponds to
the block 8/enhancer N-2 (Figure 6A; Table 1), confirm-formation (st. 12) and initiation of lens development in
concert with more widely expressed Pax6 (Kamachi et ing the conserved enhancer activity.
DNA fragments representing the conserved sequenceal., 2001); and (3) high Sox2 expression for lens develop-
ment after the vesicle stage (st. 14) in the chicken, which blocks were also analyzed by electroporation of st. 4
embryos, but indicated no enhancer other than thoseis replaced by Sox1 expression in the mouse, rendering
Sox1 knockout mouse defective in lens development shown in Figure 2 (Table 1). Electroporation of st. 11
neural tubes, however, demonstrated the presence of(Nishiguchi et al., 1998).
Enhancers exactly corresponding to all these three additional enhancers active in the spinal cord, blocks
18 (SC-1) and 22 (SC-2). In addition, block 25 (enhancerstages of lens development were identified. Enhancer
N-4 is initially active in the lateral to ventral head ecto- NC-1) was found to bear enhancer activity in the dorsal
root ganglia. These enhancer activities had been indi-derm besides mesencephalon and spinal cord (Figure
4C, arrow). The enhancer N-3 is then activated by the cated for larger DNA fragments (Figure 2, those marked
by * or **).lens induction signal of the optic vesicle (Figure 4B,
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Figure 4. Activity of Individual Sox2 Enhancers in Electroporated Chicken Embryo
(A–D) Enhancers N-2 to N-5 individually regulating Sox2 in distinct domains of the CNS.
(A) Enhancer N-2 at three embryonic stages showing the activity in the telencephalon (t), diencephalon (d), mesencephalon (m), and the
anterior rhombencephalon (r).
(B) Enhancer N-3, showing activity in the diencephalon, rostral mesencephalon, and retina (optic vesicle, ov). N-3 also shows activity in the
lens placode (lp; arrow), which is dependent on apposition by the optic vesicle. The lower panels are enlargements showing the lens placode-
optic vesicle region.
(C) Enhancer N-4 showing activity in the mesencephalon (m), rhombencephalon (activity lower in rhombomeres r2–r4), and spinal cord (sc).
This enhancer also shows activity in the lateral head ectoderm (he; arrow). This activity in the lateral head ectoderm is attenuated by st. 11.
(D) Enhancer N-5, active in the rhombencephalon from r2 to r4.
(E–G) Enhancers detected by electroporation of the st. 11 neural tube.
(E) Spinal cord enhancer activity of the DNA fragment 7.6–14 (Figure 2) containing the conserved sequence blocks 14–18.
(F) Spinal cord enhancer activity of fragment 21–25 (Figure 2) containing enhancer N-4 (conserved sequence block 24).
(G) Enhancer activity in the dorsal root ganglia of enhancer NC-1 (block 25).
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Other blocks that have not been assigned to an en- mechanisms that initiate development of these tissues.
Expression of Sox2 in the neural tissues depends on ahancer may be active in other tissues, such as esopha-
gus (Ishii et al., 1998), or in later development. Indeed, patchwork of activities of separate enhancers that have
distinct spatial and temporal specificities. Perhaps theblock 11 corresponds to the recently described en-
hancer active in mouse ES cells (Tomioka et al., 2002). expression of Sox2 is an absolute requirement for the
neuroepithelial cells, but the extracellular and intracellu-On the other hand, we have not identified enhancers for
expression in epibranchial placodes. These and some lar conditions of these cells presumably vary from one
tissue level to another and from one developmentalother enhancers may be present outside the region of
this current analysis. stage to another, and these variations necessitate the
contribution of numerous enhancers of different speci-Thus, the data demonstrate that the Sox2 enhancers
are highly conserved between chicken and mammals, ficities to establish a uniform and continuous Sox2 ex-
pression. These enhancers correspond to an array ofand the corresponding enhancers are arranged colin-
early in the genomes (Figure 6A). Comparison of the phylogenically conserved extragenic sequences, which
are clearly definable by comparing chicken and mamma-chicken sequence with fugu (puffer fish) Sox2 locus
(scaffold 2806) indicated that blocks 4 and 10 are con- lian sequences. Thus, comparison of chicken and mam-
malian genome sequences provides definitive informationserved in the fish, but the other blocks are not (data not
shown). Sequence comparison between the mouse and to identify and characterize the regulatory sequences.
human genomes, however, showed that the enhancer
Experimental Proceduresregions are buried within longer stretches of sequence
similarity (Figures 6A and 6D). Presumably the phylo-
Genomic Clones of the Chicken Sox2 Locusgenic distance between birds and mammals is optimal
and Sequence Analysis
for identifying the conserved regulatory sequences. Sox2 genomic clones G53 and G67 were isolated from a FIXII
The recent advance of genome sequencing has indi- genomic library of the chicken by screening with Sox2 cDNA as
probe (Kamachi et al., 1995), and additional clones U3 and D1 bycated that conserved sequences of noncoding regions
walking (Figure 2). Comparison of the sequences was done usingare candidates for genetic regulatory regions, but strate-
Pustell matrix analysis (Pustell and Kafatos, 1982) in MacVectorgies to sort out functionally significant conserved re-
software. The hash size, window size, and minimal percent scoresgions have been sought (see Hardison, 2000 for review).
were chosen as six, 30, and 60, respectively. When a valid match
Our analysis shown in Figure 6 demonstrates that, at was found, we examined to see whether the conserved sequence
least in the extragenic sequences of the Sox2 locus, with no lower than 60% identity continues over 100 bp in length.
The sequence alignment was also confirmed by the VISTA (Mayorsequence conservations between chicken and mam-
et al., 2000) and Gene Works programs.mals are a reliable indication of functional enhancers.
This observation may be generalized; that is, if an array
Plasmid Constructionof sequence blocks is conserved between chicken and
The plasmid ptkEGFP was constructed by insertion of the Herpesmammals and is associated with a genetic locus, it likely
simplex virus thymidine kinase promoter in the polylinker HindIII site
represents a set of important regulatory sequences. In- of pCAT3-basic vector (Promega), and by replacing the CAT gene
deed, there is a precedence that a missing neural en- with the EGFP gene (Clontech). To identify enhancers associated
with the Sox2 locus, various DNA fragments of Sox2 and flankinghancer of SCL gene was identified as a sequence block
sequences were inserted in the polylinker SmaI site of ptkEGFP. Inconserved between chicken and mammals and located
some cases, d2EGFP (Clontech), a destabilized form EGFP, wasdistantly from the gene (Gottgens et al., 2000).
employed for the coding region, but the expression pattern in theComparison of chicken and mouse sequences is sen-
embryo was indistinguishable between EGFP and d2EGFP, whereas
sitive enough to identify subtle differences of Sox2 regu- fluorescence was brighter with the former, causing us to compile
lation between the species. The late lens enhancer (L) the full data set with EGFP-encoding vectors.
of the chicken has no counterpart in the mouse genome,
accounting for the absence of Sox2 expression in the Electroporation
We adopted electroporation to transfer plasmid DNA into the epi-mouse lens after the lens vesicle stage (Kamachi et al.,
blast/ectoderm layer of early chicken embryos. Stage 4 chicken1998; Nishiguchi et al., 1998). It is interesting to note
embryos (Hamburger and Hamilton, 1951) were cultured by a modi-that some of the blocks conserved between chicken
fied New technique (Kamachi et al., 1998). An egg containing a
and human (blocks 3, 21, and 25) are not found in the staged embryo was delivered from the shell in a 10 cm dish. Thick
mouse sequence (Figure 6A, boxes labeled “h”; Table 1). albumen was removed from the area surrounding the blastoderm,
a ring of filter paper was placed on the vitelline membrane encircling
the blastoderm, and the membrane was cut at the circumferenceConclusions
of the filter ring. The embryo anchored to the filter ring through theWe identified distinct enhancers for Sox2 expression in
vitelline membrane was transferred into warmed Hank’s solution,
the embryonic CNS and placodes, including those re- and gently washed to remove the adhering yolk. The embryo was
sponding to signals for neural and lens induction. Analysis placed upside down (vitelline membrane side down) onto the elec-
trode (cathode), which was made of platinum foil 2  2 mm squareof these enhancers will allow the unveiling of molecular
(H–J) Enhancers are active only in the placodal lineages.
(H) Enhancer NOP-1, having activity in nasal (np) and otic (op) placodes.
(I) Enhancer NOP-2, having activity in nasal (np) and otic (op) placodes, similar to NOP-1.
(J) Enhancer L, having activity in the lens (l) after the lens vesicle stage.
The orange fluorescence in (B), (H), and (I) is derived from strong DsRed1 expression in extraembryonic tissues.
st., developmental stages; h, hours after electroporation.
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Figure 5. Nucleotide Sequences of the Identified Early Neural Enhancers of the Chicken Sox2 Locus, and Alignment with the Corresponding
Mouse and Human Sequences
Enhancers N-1 (A), N-2 (B), N-3 (C), N-4 (D), and N-5 (E). Sequences are shaded when the nucleotide residue is conserved in two of the
species. Putative binding sequences of various transcription factors conserved among the animal species are underlined; putative binding
sequences of SOX/LEF/TCF proteins ([A/T][A/T]CAA[A/T](G)), POU proteins (CATN0-3[T/A]AAT), and EF1/SIP1 proteins (CACCT(G)) (Sekido et
al., 1994, 1997; Verschueren et al., 1999) overlapping with E2 box (CACCTG), homeodomain (HD) proteins (ATTA), and E box (CANNTG).
Sox2 Neurosensory Enhancers
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Figure 6. Conservation of the Identified Enhancers across Species in Amniotes
(A) Summary of the analysis of conserved sequence blocks of the Sox2 locus. The blocks of sequences (60% identity over 100 bp)
conserved between chicken and mouse and between chicken and human are indicated as boxes on the maps of respective animal species.
The Sox2 coding sequence is shown in green. The Sox2 enhancers shown in Figure 2 are indicated using the same color codes. These match
the conserved sequence blocks except for enhancer L, which is unique to the chicken. The blocks labeled (h) are conserved between the
chicken and human but not in the mouse. The regions of sequence conservation between mouse and human determined by the same criteria
are indicated in blue.
(B–D) Dot matrix analysis comparing the nucleotide sequences encompassing the conserved sequence block 14 corresponding to enhancer
N-5. A dot was produced with the window size of ten nucleotides and the minimal score of 60% identity.
(B) Comparison of chicken and mouse sequences.
(C) Comparison of chicken and human sequences.
(D) Comparison of mouse and human sequences. Note that the block 14 (enhancer N-5) sequence is embedded in a longer stretch of sequence
similarity when the sequence comparison is made between mouse and human.
fixed to the bottom of the chamber. A DNA solution containing the 6% hydrogen peroxide in PBT for 1 hr, followed by two PBT washes.
Embryos were treated with 10 g/ml proteinase K for appropriatereporter plasmid (1 l volume with a final concentration of 2 g/
l) and the marker plasmid (pMiwZ or pDsRed1-N1 [Clontech], 1 g/ periods depending on their stages, washed briefly in PBT, and re-
fixed in 0.2% glutaraldehyde/4% PFA in PBT for 20 min. They werel) was injected between the blastoderm and the vitelline membrane
using a glass capillary. An anodal electrode was quickly placed on then washed twice in PBT for 10 min, and preincubated in hybridiza-
tion buffer (50% formamide, 5 SSC [pH 5], 1% CHAPS, 50 g/mlthe hypoblast side of the embryo with the interelectrode distance of
4 mm. Electroporation was performed using a CUY21 electroporator heparin, 50 g/ml yeast tRNA) for 1 hr at 70C. Hybridization with
0.5–1 g/ml digoxigenin-labeled Sox2 RNA probe (Kamachi et al.,(BEX) with five pulses of 10 volts for a duration of 50 msec and with
intervals of 100 msec. The embryo was rinsed with warmed Hank’s 1998) was carried out overnight at 70C. The embryos were washed
twice in solution 1 (50% formamide, 5 SSC [pH 5], 1% SDS) forsolution and incubated with the hypoblast side up on the agar culture
medium made of liquid albumen, 0.15% glucose, 61.5 mM NaCl, 30 min at 70C. After three quick washes with solution 2 (0.5 M NaCl,
10 mM Tris-HCl [pH 7.5], 0.1% Tween-20) at 37C, the embryos wereand 0.3% agar noble (DIFCO). The embryo was overlaid with 5%
yolk supernatant in Hank’s solution and incubated at 38C with treated with 100 g/ml RNase A in solution 2 for 30 min at 37C.
They were rinsed in solution 2, then in solution 3 (50% formamide,100% humidity overnight. To examine the effect of an ectopic node,
a chicken embryo was electroporated as described above, and 2 SSC [pH 5]), washed twice in solution 3 at 65C for 30 min, and
three times in TBST (150 mM NaCl, 100 mM Tris-HCl [pH 7.5], 0.1%Hensen’s node of stage 4 quail embryo was excised using a tungsten
needle and grafted onto the host chick embryo at the position of Tween-20) for 5 min each time. After treatment with 1.5% blocking
area pellucida-area opaca boundary or at the position of area opaca reagent (Roche) in TBST for 1 hr, the embryos were incubated over-
with the same anteroposterior level as the host node. night at 4C with alkaline phosphatase-conjugated anti-digoxigenin
antibody diluted to 1/2500 and preabsorbed with chick embryo pow-
der. The embryos were then washed several times in TBST for 1 hrWhole-Mount In Situ Hybridization
each at 4C, followed by an overnight wash. After three washingsEmbryos were fixed overnight in 4% paraformaldehyde (PFA) in
in NTMT (100 mM NaCl, 100 mM Tris-HCl [pH 9.5], 50 mM MgCl2,phosphate-buffered saline (PBS) at 4C, washed twice in PBT (PBS
0.1% Tween-20, 2 mM levamisole) for 10 min each time, the embryoscontaining 0.1% Tween-20), and dehydrated with 25%, 50%, and
were incubated in NTMT containing 4.5 l NBT and 3.5 l BCIP per75% methanol in PBT, and then with 100% methanol and stored.
ml or in BM purple (Roche) until the color developed. After theThe embryos were rehydrated through the methanol/PBT series in
reverse and washed twice in PBT; they were then bleached with staining reaction was terminated, the embryos were fixed further
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Table 1. Identified Enhancers of Sox2 Gene and Their Conservation across Amniote Species
Similarity in
Conserved Assigned Activity before Enhancer Human Similarity in
Sequence st. 20 (the Earliest Stage Activity at Length in Chicken Position in Chicken Sequence Mouse Sequence
Block Enhancer of Enhancer Activity) st. 23 Sequence (bp) Sequencee (%) (%)
1 None Noned 496 	16175 to 	15680 77 68
2 N-3 Di/mesencepalon early 582 	15133 to 	14552 89 71
lens (st. 8)
3 None 487 	11102 to 	10616 62 Absentf
4 None 875 	10068 to 	9194 71 68
5 NOP-1 Nasal and otic placodes Noned 323 	8311 to 	7989 83 81
(st. 11)
6 None 145 	7803 to 	7659 75 68
7 None 143 	5310 to 	5168 75 71
8 N-2 Tel/di/mesencephalon Noned 534 	3012 to 	2479 90 87
(st. 5c)
9 None 147 	1198 to 	1052 84 81
10a Noneb None 2768 	662 to 2106 69 69
11 None Noned 103 3427 to 3529 63 61
12 None 287 4314 to 4600 83 83
13 NOP-2 Nasal and otic placodes 374 5105 to 5478 85 77
(st. 11)
14 N-5 Rhombencephalon None 366 8151 to 8516 75 72
(r2–r4) (st. 12)
15 None None 188 9872 to 10059 71 71
16 None None 344 10445 to 10788 87 86
17 N-1 Neural induction None 298 12825 to 13122 83 72
(st. 5c)
18 SC-1 None Spinal cord 413 13686 to 14098 81 65
19 None None 362 15041 to 15402 84 80
20 None None 127 16389 to 16515 74 61
21 None None 292 16988 to 17279 61 Absentf
22 SC-2 None Spinal cord 171 18450 to 18620 70 69
23 None None 158 20551 to 20708 67 (55)g
24 N-4 Head ectoderm Spinal cord 480 22339 to 22818 78 73
Mesencephalon
Spinal cord (st. 10)
L Late lens (st. 17) None 224 26592 to 26815 Absentf Absentf
25 NC-1 None Dorsal root 676 29610 to 30285 85 Absentf
ganglia
a The block including the Sox2 coding region.
b The Sox2 promoter (Wiebe et al., 2000) did not show any significant specificity in the assay.
c The earliest stage of detectable EGFP expression after electroporation at st. 4. The enhancer activity must have been present before st. 5.
d Large fragments including two to four conserved blocks were analyzed.
e The position of the Sox2 translational initiation site is taken as 1.
f “Absent” indicates no corresponding blocks identified even under less stringent conditions for detecting a sequence similarity.
g A block of sequence with similarity score of 55% is found in the corresponding region, although the score does not satisfy the condition for
registering as a conserved sequence block (similarity higher than 60%).
with 4% PFA in PBT overnight at 4C. When in situ hybridization References
was done in sequence using two different probes, the color reaction
was done with INT/BCIP for the first hybridization reaction. After Brown, J.M., and Storey, K.G. (2000). A region of the vertebrate
neural plate in which neighbouring cells can adopt neural or epider-photographic recording, the developed pigments were removed by
mal fates. Curr. Biol. 10, 869–872.washing in methanol and then the second probe was applied for
hybridization reaction, and the color of the signal was developed Cai, J., Wu, Y., Mirua, T., Pierce, J.L., Lucero, M.T., Albertine, K.H.,
using NBT/BCIP. Spangrude, G.J., and Rao, M.S. (2002). Properties of a fetal multipo-
tent neural stem cell (NEP cell). Dev. Biol. 251, 221–240.
Clevers, H., and van de Wetering, M. (1997). TCF/LEF factor earn
Acknowledgments their wings. Trends Genet. 13, 485–489.
Collignon, J., Sockanathan, S., Hacker, A., Cohen-Tannoudji, M.,We thank members of the Kondoh laboratory for stimulating discus-
Norris, D., Rastan, S., Stevanovic, M., Goodfellow, P.N., and Lovell-sions. This work was supported by grants from the Ministry of Edu-
Badge, R. (1996). A comparison of the properties of Sox-3 withcation, Science, Sports, and Culture of Japan, and from the Human
Sry and two related genes, Sox-1 and Sox-2. Development 122,Frontier Science Program.
509–520.
Dailey, L., and Basilico, C. (2001). Coevolution of HMG domains and
homeodomains and the generation of transcriptional regulation byReceived: December 3, 2002
Sox/POU complexes. J. Cell Physiol. 186, 315–328.Revised: February 4, 2003
Published: April 7, 2003
Sox2 Neurosensory Enhancers
519
Darnell, D.K., Stark, M.R., and Schoenwolf, G.C. (1999). Timing and chicken Sox2 and Sox3 genes in ectoderm induced to form neural
tissue. Dev. Dyn. 209, 323–332.cell interactions underlying neural induction in the chick embryo.
Development 126, 2505–2514. Schepers, G.E., Teasdale, R.D., and Koopman, P. (2002). Twenty
pairs of sox: extent, homology, and nomenclature of the mouse andFernandez-Garre, P., Rodriguez-Gallardo, L., Gallego-Diaz, V., Al-
human sox transcription factor gene families. Dev. Cell 3, 167–170.varez, I.S., and Puelles, L. (2002). Fate map of the chicken neural
plate at stage 4. Development 129, 2807–2822. Schilham, M.W., and Clevers, H. (1998). HMG box containing tran-
scription factors in lymphocyte differentiation. Semin. Immunol. 10,Gottgens, B., Barton, L.M., Gilbert, J.G., Bench, A.J., Sanchez, M.J.,
127–132.Bahn, S., Mistry, S., Grafham, D., McMurray, A., Vaudin, M., et al.
(2000). Analysis of vertebrate SCL loci identifies conserved en- Sekido, R., Murai, K., Funahashi, J., Kamachi, Y., Fujisawa-Sehara,
hancers. Nat. Biotechnol. 18, 181–186. A., Nabeshima, Y., and Kondoh, H. (1994). The -crystallin enhancer-
binding protein EF1 is a repressor of E2-box-mediated gene activa-Hamburger, V., and Hamilton, H.L. (1951). A series of normal stages
tion. Mol. Cell. Biol. 14, 5692–5700.in the development of the chick embryo. J Morphol. 88, 49–92.
Sekido, R., Murai, K., Kamachi, Y., and Kondoh, H. (1997). TwoHardison, R.C. (2000). Conserved noncoding sequences are reliable
mechanisms in the action of repressor EF1: binding site competi-guides to regulatory elements. Trends Genet. 16, 369–372.
tion with an activator and active repression. Genes Cells 2, 771–783.
Ishii, Y., Rex, M., Scotting, P.J., and Yasugi, S. (1998). Region-spe-
Storey, K.G., Crossley, J.M., De Robertis, E.M., Norris, W.E., andcific expression of chicken Sox2 in the developing gut and lung
Stern, C.D. (1992). Neural induction and regionalisation in the chickepithelium: regulation by epithelial-mesenchymal interactions. Dev.
embryo. Development 114, 729–741.Dyn. 213, 464–475.
Streit, A., Sockanathan, S., Perez, L., Rex, M., Scotting, P.J., Sharpe,Josephson, R., Muller, T., Pickel, J., Okabe, S., Reynolds, K., Turner,
P.T., Lovell-Badge, R., and Stern, C.D. (1997). Preventing the lossP.A., Zimmer, A., and McKay, R.D. (1998). POU transcription factors
of competence for neural induction: HGF/SF, L5 and Sox-2. Devel-control expression of CNS stem cell-specific genes. Development
opment 124, 1191–1202.125, 3087–3100.
Tomioka, M., Nishimoto, M., Miyagi, S., Katayanagi, T., Fukui, N.,Kamachi, Y., Sockanathan, S., Liu, Q., Breitman, M., Lovell-Badge,
Niwa, H., Muramatsu, M., and Okuda, A. (2002). Identification ofR., and Kondoh, H. (1995). Involvement of SOX proteins in lens-
Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2specific activation of crystallin genes. EMBO J. 14, 3510–3519.
complex. Nucleic Acids Res. 30, 3202–3213.
Kamachi, Y., Uchikawa, M., Collignon, J., Lovell-Badge, R., and
Uchikawa, M., Kamachi, Y., and Kondoh, H. (1999). Two distinctKondoh, H. (1998). Involvement of Sox1, 2 and 3 in the early and
subgroups of Group B Sox genes for transcriptional activators andsubsequent molecular events of lens induction. Development 125,
repressors: their expression during embryonic organogenesis of the2521–2532.
chicken. Mech. Dev. 84, 103–120.
Kamachi, Y., Uchikawa, M., and Kondoh, H. (2000). Pairing SOX off:
Uwanogho, D., Rex, M., Cartwright, E.J., Pearl, G., Healy, C., Scot-
with partners in the regulation of embryonic development. Trends
ting, P.J., and Sharpe, P.T. (1995). Embryonic expression of the
Genet. 16, 182–187.
chicken Sox2, Sox3 and Sox11 genes suggests an interactive role
Kamachi, Y., Uchikawa, M., Tanouchi, A., Sekido, R., and Kondoh, in neuronal development. Mech. Dev. 49, 23–36.
H. (2001). Pax6 and SOX2 form a co-DNA-binding partner complex Verschueren, K., Remacle, J.E., Collart, C., Kraft, H., Baker, B.S.,
that regulates initiation of lens development. Genes Dev. 15, 1272– Tylzanowski, P., Nelles, L., Wuytens, G., Su, M.T., Bodmer, R., et
1286. al. (1999). SIP1, a novel zinc finger/homeodomain repressor, inter-
Kishi, M., Mizuseki, K., Sasai, N., Yamazaki, H., Shiota, K., Nakanishi, acts with Smad proteins and binds to 5-CACCT sequences in candi-
S., and Sasai, Y. (2000). Requirement of Sox2-mediated signaling date target genes. J. Biol. Chem. 274, 20489–20498.
for differentiation of early Xenopus neuroectoderm. Development Wegner, M. (1999). From head to toes: the multiple facets of Sox
127, 791–800. proteins. Nucleic Acids Res. 27, 1409–1420.
Li, H.S., Yang, J.M., Jacobson, R.D., Pasko, D., and Sundin, O. Wiebe, M.S., Wilder, P.J., Kelly, D., and Rizzino, A. (2000). Isolation,
(1994). Pax-6 is first expressed in a region of ectoderm anterior to characterization, and differential expression of the murine Sox-2
the early neural plate: implications for stepwise determination of promoter. Gene 246, 383–393.
the lens. Dev. Biol. 162, 181–194.
Wilson, M., and Koopman, P. (2002). Matching SOX: partner proteins
Mathis, L., Kulesa, P.M., and Fraser, S.E. (2001). FGF receptor signal- and co-factors of the SOX family of transcriptional regulators. Curr.
ling is required to maintain neural progenitors during Hensen’s node Opin. Genet. Dev. 12, 441–446.
progression. Nat. Cell Biol. 3, 559–566.
Wood, H.B., and Episkopou, V. (1999). Comparative expression of
Mayor, C., Brudno, M., Schwartz, J.R., Poliakov, A., Rubin, E.M., the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to
Frazer, K.A., Pachter, L.S., and Dubchak, I. (2000). VISTA: visualizing early somite stages. Mech. Dev. 86, 197–201.
global DNA sequence alignments of arbitrary length. Bioinformatics Zappone, M.V., Galli, R., Catena, R., Meani, N., De Biasi, S., Mattei,
16, 1046–1047. E., Tiveron, C., Vescovi, A.L., Lovell-Badge, R., Ottolenghi, S., and
Mizuseki, K., Kishi, M., Matsui, M., Nakanishi, S., and Sasai, Y. (1998). Nicolis, S.K. (2000). Sox2 regulatory sequences direct expression
Xenopus Zic-related-1 and Sox-2, two factors induced by chordin, of a (
)-geo transgene to telencephalic neural stem cells and precur-
have distinct activities in the initiation of neural induction. Develop- sors of the mouse embryo, revealing regionalization of gene expres-
ment 125, 579–587. sion in CNS stem cells. Development 127, 2367–2382.
Nishiguchi, S., Wood, H., Kondoh, H., Lovell-Badge, R., and Episko-
pou, V. (1998). Sox1 directly regulates the -crystallin genes and is Accession Numbers
essential for lens development in mice. Genes Dev. 12, 776–781.
The compiled 49.2 kb sequence of the chicken Sox2 locus is in thePevny, L.H., and Lovell-Badge, R. (1997). Sox genes find their feet.
GenBank/DDBJ databases (AB092842). The Sox2 locus sequencesCurr. Opin. Genet. Dev. 7, 338–344.
of the mouse, human, and fugu are AL606746 (GenBank), AC117415
Pevny, L.H., Sockanathan, S., Placzek, M., and Lovell-Badge, R.
(GenBank), and CAAB01002806 (The Fugu Genome Sequencing
(1998). A role for SOX1 in neural determination. Development 125,
Consortium), respectively.
1967–1978.
Pustell, J., and Kafatos, F.C. (1982). A high speed, high capacity
homology matrix: zooming through SV40 and polyoma. Nucleic
Acids Res. 10, 4765–4782.
Rex, M., Orme, A., Uwanogho, D., Tointon, K., Wigmore, P.M.,
Sharpe, P.T., and Scotting, P.J. (1997). Dynamic expression of
